The research uses Machine Learning technology to look at Structural features within the brain, including in regions not previously associated with Alzheimer’s. The advantage of the technique is its simplicity and the fact that it can identify the disease at an early stage when it can be very difficult to diagnose.

Although there is no cure for Alzheimer’s disease, getting a diagnosis quickly at an early stage helps patients. It allows them to access help and support, get treatment to manage their symptoms and plan for the future...

Advance shows promise for ”meta-bots’ designed to deliver drugs or aid rescue missions. A team of UCLA engineers and their colleagues have developed a new design strategy and 3D printing technique to build robots in one single step.

A study that outlined the advance, along with the construction and demonstration of an assortment of tiny robots that walk, maneuver and jump, was published in Science.

The breakthrough enabled the entire mechanical and electronic systems needed to operate a robot to be manufactured all at once by a new type of 3D printing process for engineered active materials with multiple functions (also known as metamaterials)...

A University of Arizona-led team of astronomers has created a detailed, 3D image of a dying hypergiant star. The team, led by UArizona researchers Ambesh Singh and Lucy Ziurys, traced the distribution, directions and velocities of a variety of molecules surrounding a red hypergiant star known as VY Canis Majoris.

Their findings, which they presented on June 13 at the 240th Meeting of the American Astronomical Society in Pasadena, California, offer insights, at an unprecedented scale, into the processes that accompany the death ...

Longitudinal study describes short- and long-term neurological symptoms of SARS-CoV-2 infection; identifies new subgroup with advanced symptoms. Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 “long-haulers.”

The first round of results, published June 15, 2022 in Annals of Clinical and Translational Neurology, revealed the prevalence of various short- and long-term symptoms and found that, while many patients showed improvement, the majority still had some neurological symptoms after six months...